A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
Trial details
- Registry ID
- NCT06291857
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as COVID-19 and influenza combination
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination VaccineNCT06291857 | Novavax | Phase 3 | Completed | 2025-12-24Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |